Glomerular deposition of mannose-binding lectin (MBL) indicates a novel mechanism of complement activation in IgA nephropathy

被引:158
|
作者
Endo, M [1 ]
Ohi, H [1 ]
Ohsawa, I [1 ]
Fujita, T [1 ]
Matsushita, M [1 ]
Fujita, T [1 ]
机构
[1] Fukushima Med Coll, Dept Biochem, Fukushima, Japan
关键词
complement; IgA nephropathy; mannose-binding lectin; mannose-binding lectin associated serine protease;
D O I
10.1093/ndt/13.8.1984
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. IgA nephropathy (IgA-N) is considered the most common glomerular disease in the world and leads to renal failure in a substantial number of patients. Although many studies have looked at the pathogenesis of the disease, many points need to be clarified, including the mechanism of complement activation. Recent studies have shown that mannose-binding lectin (MBL or mannose binding protein, MBP) initiates activation of the complement cascade (lectin pathway) utilizing two types of MBP-associated serine protease, namely MASP-1 and MASP-2. The present study was undertaken to elucidate whether the lectin pathway was involved in the pathogenic mechanism of IgA-N. Methods. Forty-five renal biopsy cases with IgA-N, 35 cases with other forms of glomerulonephritis (GN), and normal kidney tissues were collected and an immunohistochemical study was performed using monoclonal antibodies against MBL and MASP-1. Furthermore, clinicopathological and serological features were also analysed in the patients with IgA-N. Results. Glomerular deposition of MEL, which was accompanied by MASP-1, was detected in 11 of 45 (24.4%) cases with IgA-N, while it was detected in only one case with other forms of GN. The deposited MBL/MASP-1 was observed to associate with C3b/C3c and C5b-9 but not with IgG, IgM, Clq, C4c, or properdin. Compared with MBL/MASP-1 negative cases with IgA-N, the positive cases with IgA-N were young and the renal biopsies had been performed at an early stage of the disease. No significant correlation was found between glomerular deposition of MBL/MASP-1 and proteinuria, haematuria, creatinine clearance, and serum levels of IgA, C3, or C4 at the time of renal biopsy. There were also no significant differences between MBL/MASP-1 positive cases and negative cases in the plasma levels of circulating immune complexes or soluble C5b-9. Conclusion. The lectin pathway of complement activation, which is initiated by the MBL/MASPs complex, evidently contributes to the development of glomerular injury in a significant number of cases with IgA-N. In addition, these findings will add insight to the pathogenesis of IgA-N, including its relation to infection, since MBL plays a crucial role in the host defense against various pathogens.
引用
收藏
页码:1984 / 1990
页数:7
相关论文
共 50 条
  • [31] Circulating levels of mannose-binding lectin (MBL) in age-related macular degeneration
    Pradella, Fernando M.
    Nisihara, Renato
    Sato, Mario T.
    Grandinetti, Alexandre A.
    Novello, Sergio B.
    Pires, Marcelo
    Schebelski, Diego
    Messias-Reason, Iara
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2018, 81 (02) : 120 - 124
  • [32] Mannose-binding lectin (MBL) therapy in an MBL-deficient patient with severe cystic fibrosis lung disease
    Garred, P
    Pressler, T
    Lanng, S
    Madsen, HO
    Moser, C
    Laursen, I
    Balstrup, F
    Koch, C
    Koch, C
    PEDIATRIC PULMONOLOGY, 2002, 33 (03) : 201 - 207
  • [33] Low mannose-binding lectin complement activation function is associated with predisposition to Legionnaires' disease
    Eisen, D. P.
    Stubbs, J.
    Spilsbury, D.
    Carnie, J.
    Leydon, J.
    Howden, B. P.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 149 (01): : 97 - 102
  • [34] Emerging role of the mannose-binding lectin-dependent pathway of complement activation in clinical organ transplantation
    Berger, Stefan P.
    Daha, Mohamed R.
    CURRENT OPINION IN ORGAN TRANSPLANTATION, 2011, 16 (01) : 28 - 33
  • [35] Activation of the alternative complement pathway by mannose-binding lectin via a C2-bypass pathway
    Tateishi, Koichiro
    Matsushita, Misao
    MICROBIOLOGY AND IMMUNOLOGY, 2011, 55 (11) : 817 - 821
  • [36] Mannose-Binding Lectin and Diabetic Nephropathy in Type 1 Diabetes
    Zhao, Shi-qi
    Hu, Zhao
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2016, 30 (04) : 345 - 350
  • [37] Complement and Mannose-Binding Lectin 2 Polymorphism in Meningococcal Disease
    Lima Filho, Alberto
    Carmo, Rodrigo
    Cavalcanti, Maria
    Vasconcelos, Luydson
    Moura, Patricia
    Silva, Almerinda
    Sarinho, Emanuel
    CLINICAL LABORATORY, 2012, 58 (11-12) : 1165 - 1169
  • [38] Polymorphisms of the mannose-binding lectin gene MBL in periodontitis in patients with Down syndrome
    Imamura, Yasuhiro
    Aoki, Hakuei
    Oomori, Yuriko
    Miyazawa, Hiroo
    Wang, Pao-Li
    PEDIATRIC DENTAL JOURNAL, 2011, 21 (01) : 17 - 23
  • [39] Augmented mannose-binding lectin levels in primary membranous nephropathy: A pilot study
    Pal, Deeksha
    Inamdar, Neeraj
    Kaur, Prabhjot
    Singhal, Manphool
    Lal, Anupam
    Gorsi, Ujjwal
    Nada, Ritambhra
    Kohli, Harbir S.
    Kumar, Vinod
    Ramachandran, Raja
    NEPHROLOGY, 2024, 29 (09) : 617 - 621
  • [40] Leishmania (Viannia) braziliensis:: Interaction of mannose-binding lectin with surface glycoconjugates and complement activation.: An antibody-independent defence mechanism
    Ambrosio, AR
    De Messias-Reason, IJT
    PARASITE IMMUNOLOGY, 2005, 27 (09) : 333 - 340